Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
210 studies found for:    Ataxia
Show Display Options
Rank Status Study
21 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: Omaveloxolone Capsules, 2.5 mg;   Drug: Omaveloxolone Capsules, 5 mg;   Drug: Omaveloxolone Capsules, 10 mg;   Drug: Placebo;   Drug: Omaveloxolone Capsules, 20 mg;   Drug: Omaveloxolone Capsules, TBD mg;   Drug: Omaveloxolone Capsules, 40 mg;   Drug: Omaveloxolone Capsules, 80 mg;   Drug: Omaveloxolone Capsules, 160 mg;   Drug: Omaveloxolone Capsules, 300 mg
22 Active, not recruiting Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Device: Transcranial Magnetic Stimulation
23 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
24 Recruiting Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Biological: Stemchymal®;   Procedure: Excipients
25 Completed Body Composition and Hormonal Status in Ataxia Telangiectasia
Condition: Ataxia Telangiectasia
Interventions: Procedure: bioelectrical impedance analysis;   Procedure: blood draw
26 Completed Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
27 Recruiting Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Condition: Friedreich's Ataxia
Intervention:
28 Completed
Has Results
An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: bupropion & Citalopram;   Drug: Bupropion & Placebo;   Drug: Placebo & Citalopram;   Drug: Placebo & Placebo
29 Enrolling by invitation Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia Study
Condition: Friedreich's Ataxia
Intervention: Drug: Interferon γ-1b
30 Completed
Has Results
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
Condition: Friedreich's Ataxia
Interventions: Drug: idebenone;   Drug: Placebo
31 Enrolling by invitation Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention:
32 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
33 Recruiting Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Condition: Spinocerebellar Ataxia
Intervention:
34 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
35 Completed Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Condition: Ataxia-Telangiectasia
Interventions: Drug: vinblastine, vincristine, prednisone, daunorubicin;   Drug: doxorubicin, methotrexate, cyclophosphamide, L-asparaginase;   Drug: etoposide, cytarabine, mercaptopurine;   Drug: dexamethasone, procarbazine;   Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy
36 Recruiting An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxias
Intervention: Drug: Intravenous Immune Globulin (IVIG)
37 Completed Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Biological: IVIG
38 Unknown  Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia
Condition: Hereditary Ataxia
Intervention: Biological: human umbilical cord mesenchymal stem cells
39 Recruiting A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiography (ECHO);   Procedure: Cardiac-related blood studies
40 Recruiting (+) Epicatechin to Treat Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: (+)-Epicatechin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.